Keywords:
arterial hypertension, overweight, obesity, cardiovascular diseases.References
Daminova, K. M. (2011). Dermatoglyphic indicators in patients with metabolic syndrome. Journal "Doctor-Postgraduate", Voronezh, (1.2[44]), 265–269.
Ismailov, S. I., & Rashitov, M. M. (2016). Progress in the prevention of iodine deficiency disorders in the Republic of Uzbekistan (2004–2016). Clinical and Experimental Thyroidology, 12(3), 20–24.
Ismailov, S. I., & Muminova, S. U. (2019). The role of dyslipidemia in the development of nephropathy in patients with type 2 diabetes mellitus (literature review). International Endocrinology Journal, 15(8), 644–648.
Kayumov, U. K. (2019). Recipe for all diseases. Health of Uzbekistan, 3(36), 4–7.
Shagazatova, B. Kh. (2013). Assessment of the quality of outpatient follow-up of patients with diabetes mellitus. Medical Practice.
Stroeva, M. V., & Mamedov, M. N. (2010). Prognostic significance of the metabolic effects of antihypertensive drugs in the development of cardiovascular disease and diabetes mellitus. Cardiovascular Therapy and Prevention, 9(2), 80–85.
Norgaard, S. K., Vestgaard, M. J., Jorgensen, I. L., Asbjornsdottir, B., Ringholm, L., McIntyre, H. D., Damm, P., & Mathiesen, E. R. (2018). Diastolic blood pressure is a potentially modifiable risk factor for preeclampsia in women with pre-existing diabetes. Diabetes Research and Clinical Practice, 138, 229–237.
Marott, S. C., Nordestgaard, B. G., Tybjaerg-Hansen, A., & Benn, M. (2016). Components of the metabolic syndrome and risk of type 2 diabetes. Journal of Clinical Endocrinology & Metabolism, 101(8), 3212–3221.
Lu, J., Wang, L., Li, M., Xu, Y., Jiang, Y., Wang, W., Li, J., Mi, S., Zhang, M., Li, Y., et al. (2016). Metabolic syndrome among adults in China – The 2010 China Noncommunicable Disease Surveillance. Journal of Clinical Endocrinology & Metabolism, jc20162477.
Matsushita, K., Coresh, J., Sang, Y., et al. (2015). Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: A collaborative meta-analysis of individual participant data. Lancet Diabetes & Endocrinology, 3, 514–525. https://doi.org/10.1016/S2213-8587(15)00040-6
Peters, S. A., Huxley, R. R., & Woodward, M. (2014). Diabetes as a risk factor for incident coronary heart disease in women compared with men: A systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events. Diabetologia, 57, 1542–1551. https://doi.org/10.1007/s00125-014-3260-6
Bethel, M. A., Patel, R. A., Merrill, P., et al. (2018). Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: A meta-analysis. Lancet Diabetes & Endocrinology, 6(2), 105–113. https://doi.org/10.1016/S22138587(17)30412-6
Matsushita, K., Coresh, J., Sang, Y., et al. (2015). Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: A collaborative meta-analysis of individual participant data. Lancet Diabetes & Endocrinology, 3, 514–525. https://doi.org/10.1016/S2213-8587(15)00040-6
Misra, A., & Bhardwaj, S. (2014). Obesity and the metabolic syndrome in developing countries: Focus on South Asians. Nestle Nutrition Institute Workshop Series, 78, 133–140.
World Bank. (2011). Non-communicable disease in Nepal – Nepal’s next major health challenge. NCDs Policy Brief – Nepal. Washington DC, USA. Retrieved March 9, 2018.
Bhandari, G. P., Angdembe, M. R., Dhimal, M., Neupane, S., & Bhusal, C. (2014). State of non-communicable diseases in Nepal. BMC Public Health, 14, 23.
Vaidya, A. (2011). Tackling cardiovascular health and disease in Nepal: Epidemiology, strategies and implementation. Heart Asia, 3, 87–91.
Sharma, S. K., et al. (2011). Prevalence of hypertension, obesity, diabetes, and metabolic syndrome in Nepal. International Journal of Hypertension, 2011, 821971.
Chowdhury, M. Z. I., et al. (2018). Prevalence of metabolic syndrome in Bangladesh: A systematic review and meta-analysis of the studies. BMC Public Health, 18, 308.
Pandit, K., Goswami, S., Ghosh, S., Mukhopadhyay, P., & Chowdhury, S. (2012). Metabolic syndrome in South Asians. Indian Journal of Endocrinology and Metabolism, 16, 44–55.
Aryal, N., & Wasti, S. P. (2016). The prevalence of metabolic syndrome in South Asia: A systematic review. International Journal of Diabetes in Developing Countries, 36, 255–262.